Werewolf Therapeutics looks to make a killing in the public markets with a $100M IPO

April 12, 2021

ImmuneID Appoints Annalisa D’Andrea as President and Chief Scientific Officer

April 5, 2021

Armed with Pfizer’s ADC Platform, Pyxis Scores $152M Round to Shoot for the Clinic while Taking its Time on I/O Programs

April 2, 2021

Pyxis Bags $152 Million to Advance ADCs Licensed from Pfizer, LegoChem

April 1, 2021

Bicycle Therapeutics Announces Significant Progress Across Multiple Therapeutic Programs Beyond Oncology

March 31, 2021

After Pfizer Cancer Deal, Pyxis Oncology Nabs a Hefty $152M Series B

March 30, 2021